A Phase 3, Randomized, Open-Label Trial Comparing Trastuzumab Emtansine And Trastuzumab As Adjuvant Therapy For Her2-Positive Primary Breast Cancer With Residual Invasive Tumor In The Breast Or Axillary Lymph Nodes Following Preoperative Therapy (Katherine)